603 results on '"Gravas, Stavros"'
Search Results
2. Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression
3. Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study
4. Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis
5. From BPH to male LUTS: a 20-year journey of the EAU guidelines
6. Infectious complications of transrectal prostate biopsy in patients receiving targeted antibiotic prophylaxis after urethral and rectal swab versus standard prophylaxis: A prospective comparative study
7. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms
8. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression
9. European Association of Urology Guidelines on Male Urinary Incontinence
10. Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results
11. The use of an artificial neural network in the evaluation of the extracorporeal shockwave lithotripsy as a treatment of choice for urinary lithiasis
12. Hot Topics in the Clinical Practice Guidelines for Treatment of Male Lower Urinary Tract Symptoms due to Benign Prostatic Obstruction
13. Burden of Benign Prostatic Hyperplasia (BPH) in Low- and Middle-Income Countries in Sub-Saharan Africa (SSA).
14. How to avoid complications in flexible ureteroscopy
15. Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial
16. Preservation of antegrade ejaculation after surgical relief of benign prostatic obstruction is a valid endpoint
17. Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines
18. Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines
19. Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis
20. What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?
21. The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak
22. Infectious complications of transrectal prostate biopsy in patients receiving targeted antibiotic prophylaxis after urethral and rectal swab versus standard prophylaxis: A prospective comparative study
23. Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression
24. Unveiling Prostatic Inflammation to Optimize Management of Lower Urinary Tract Symptoms: A Discussion with Experts
25. Lower Urinary Tract Symptoms Including Bladder Outlet Obstruction: What’s New in Diagnostics?
26. The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study
27. Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression
28. TURPxit or not: the guidelines perspective—Panta Rhei
29. From BPH to male LUTS: a 20-year journey of the EAU guidelines
30. LBA01-02 IMPACT OF MEDICAL TREATMENT ON STORAGE VS VOIDING SYMPTOMS AND NOCTURIA FREQUENCY: A DYNAMIC NOMOGRAM N=9167 MEN WITH PROSTATIC ENLARGEMENT
31. Greek validation of the user version of the Mobile Application Rating Scale (uMARS)
32. Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study
33. Mind the gap: management of benign prostatic obstruction (BPO) surgical candidates on antithrombotics
34. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms
35. Contributors
36. The Relationship Between Inflammation and LUTS/BPH
37. Latest Evidence on Post-Prostatectomy Urinary Incontinence
38. Antibiotic use and the prevention and management of infectious complications in stone disease
39. Salvage Treatment for Recurrent Prostate Cancer Following Brachytherapy: For Whom, When and Which?
40. Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
41. Reply to Meny Lv, Xufei Luo, and Yaolong Chen’s Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012
42. Advances in Diagnostic and Therapeutic Ultrasonography
43. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
44. Transurethral Microwave Thermotherapy for Benign Prostatic Obstruction
45. A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance
46. Tolterodine in the Treatment of Male LUTS
47. Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer
48. Postoperative Infection Rates in Low Risk Patients Undergoing Percutaneous Nephrolithotomy With and Without Antibiotic Prophylaxis: A Matched Case Control Study
49. Temporary intraprostatic stents
50. How to avoid complications in flexible ureteroscopy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.